BRIEF

on EUROPLASMA (EPA:ALEUP)

EUROPLASMA: 2023 annual results

Stock price chart of EUROPLASMA (EPA:ALEUP) showing fluctuations.

Europlasma achieved a turnover of €15.4 million in 2023, up 6.1% compared to 2022. Despite supplier delays and the energy crisis, EBITDA stood at -€13.0 million. , slightly improving.

The Hazardous Waste Processing segment saw revenue decline 24%, primarily due to high energy costs.

As for the “Decarbonization” branch, it posted a 12% increase in its turnover, with a notable increase in partnerships.

Industrial activities recorded strong growth, supported by the increase in production at the Forges de Tarbes.

Finally, R&D initiatives on plasma solutions made it possible to control expenses.

R. H.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved. Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all EUROPLASMA news